Discussion: In their cross-study comparison, they concluded that this regimen was an efficient treatment strategy in moderately pre-treated patients and that virological success was observed for this regimen in the presence of the
M184V mutation and low numbers of TAMs, although the presence of at least two TAMs, especially when the
T215Y/F mutation was present, or the
L210W mutation alone was a predictor of VF.